|
CDCA4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.23470123014613E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.43269999489604E-08 |
| Normal-vs-Stage2 |
1.543590E-02 |
| Normal-vs-Stage3 |
3.2777999999789E-06 |
| Normal-vs-Stage4 |
8.596700E-03 |
| Stage1-vs-Stage2 |
9.869200E-01 |
| Stage1-vs-Stage3 |
5.936100E-03 |
| Stage1-vs-Stage4 |
2.414200E-01 |
| Stage2-vs-Stage3 |
3.414000E-02 |
| Stage2-vs-Stage4 |
3.534600E-01 |
| Stage3-vs-Stage4 |
3.704000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.35200011980908E-10 |
| Normal-vs-AfricanAmerican |
6.88679999694131E-08 |
| Normal-vs-Asian |
8.634400E-02 |
| Caucasian-vs-AfricanAmerican |
6.675600E-01 |
| Caucasian-vs-Asian |
1.428800E-01 |
| AfricanAmerican-vs-Asian |
3.886000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.99649988050521E-10 |
| Normal-vs-Female |
3.01950000003437E-07 |
| Male-vs-Female |
6.034300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.409900E-04 |
| Normal-vs-Extreme_Weight |
4.66149999711618E-08 |
| Normal-vs-Obese |
3.68449999954557E-07 |
| Normal-vs-Extreme_Obese |
1.444560E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.858400E-01 |
| Normal_Weight-vs-Obese |
5.288800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.090200E-02 |
| Extreme_Weight-vs-Obese |
1.761410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.874200E-02 |
| Obese-vs-Extreme_Obese |
2.075400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.753300E-04 |
| Normal-vs-Age(41-60Yrs) |
6.40754116432163E-12 |
| Normal-vs-Age(61-80Yrs) |
1.40479999999332E-06 |
| Normal-vs-Age(81-100Yrs) |
3.590800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.072200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.976100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.822620E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.881380E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.867680E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.127800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.05000469325023E-11 |
| Normal-VS-Type2 PRCC |
6.075400E-03 |
| Normal-VS-KIRP CIMP |
4.996600E-04 |
| Normal-VS-Unclassified PRCC |
7.63370000000929E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.960300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.455200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.281000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.442160E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.902000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.999800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.23370000000234E-05 |
| Normal-vs-N1 |
4.14469999998612E-06 |
| Normal-vs-N2 |
3.779700E-02 |
| N0-vs-N1 |
2.243800E-03 |
| N0-vs-N2 |
7.313000E-01 |
| N1-vs-N2 |
1.081000E-01 |
|
|
